Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to FDA

Conexiant

FDA: Montelukast May Impact Brain Functioning

Allergy & Immunology December 4th 2024

Oncology News Central (ONC)

FDA Approves Inavolisib Combination for Advanced Breast Cancer

Oncology, Medical October 21st 2024

Medical Professionals Reference (MPR)

FDA Clears Cologuard Plus for Colorectal Cancer Screening

Family Medicine/General Practice October 16th 2024

Epoch Health

CDC, FDA Issue Warning About Recalled Eggs Linked to Multi-State Outbreak

Emergency Medicine October 2nd 2024

Medical Professionals Reference (MPR)

FDA Clears Epitomee, an Ingestible Device for Weight Management

Endocrinology, Diabetes, Metabolism September 25th 2024

Practical Neurology

FDA Grants Breakthrough Therapy Designation to Sublingual Treatment for Acute Ischemic Stroke

Emergency Medicine September 25th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form